当前位置: X-MOL 学术Mol. Cancer Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Selected Articles from This Issue
Molecular Cancer Therapeutics ( IF 5.7 ) Pub Date : 2020-02-01
American Association for Cancer Research

### [Thakkar et al. Page 490][1] The Human Epidermal Growth Factor Receptor 3 (HER3) signals through forming heterodimers with EGFR or HER2 in order to activate the PI3K pathway. To date, targeting HER3 with antibodies has shown sub-optimal results. To combat this, Thakkar and colleagues designed a

中文翻译:

本期精选文章

### [Thakkar等。Page 490] [1]人类表皮生长因子受体3(HER3)通过与EGFR或HER2形成异源二聚体来激活PI3K途径。迄今为止,用抗体靶向HER3已显示次优结果。为了解决这个问题,Thakkar及其同事设计了一个
更新日期:2020-02-07
down
wechat
bug